World Top 100 Healthcare Companies List by Market Cap in January 2024

World Top 100 Healthcare Companies List by Market Cap in January 2024, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as pf Jan-05-2024.

World Top Healthcare Companies in 2024
World Top Healthcare Companies by Market Cap in 2024, World Top Healthcare Companies by Market Cap in 2024.

  1. Atrion Corporation

    World Rank (Jan-05-2024)
    10,655
    Market Cap (Jan-05-2024)
    0.690 Billion USD
    World Rank (Jul-30-2023)
    8,766
    Market Cap (Jul-30-2023)
    0.995 Billion USD
    World Rank (Dec-25-2022)
    8,385
    Market Cap (Dec-25-2022)
    0.994 Billion USD
    World Rank (Jan-07-2022)
    8,453
    Market Cap (Jan-07-2022)
    1.21 Billion USD
    Annual Revenue in USD
    183 Million USD
    Annual Operating Income in USD
    40 Million USD
    Annual Net Income in USD
    35 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Atrion Corporation is a supplier of Medical Devices and components to niche markets in the health care and medical industry. The company products ranging from cardiovascular and ophthalmology products to fluid delivery devices are sold to end users, distributors and other manufacturers worldwide. The headquarters is in USA.
    Company Website
    ATRION CORPORATION

  2. Hunan Fangsheng Pharmaceutical

    World Rank (Jan-05-2024)
    10,665
    Market Cap (Jan-05-2024)
    0.690 Billion USD
    World Rank (Jul-30-2023)
    11,294
    Market Cap (Jul-30-2023)
    0.631 Billion USD
    World Rank (Dec-25-2022)
    12,730
    Market Cap (Dec-25-2022)
    0.476 Billion USD
    World Rank (Jan-07-2022)
    14,181
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Headquarters Country
    China
    Yahoo @ Shanghai
    Company Website
    HUNAN FANGSHENG PHARMACEUTICAL

  3. Well Health Technologies

    World Rank (Jan-05-2024)
    10,667
    Market Cap (Jan-05-2024)
    0.690 Billion USD
    World Rank (Jul-30-2023)
    9,648
    Market Cap (Jul-30-2023)
    0.840 Billion USD
    World Rank (Dec-25-2022)
    13,205
    Market Cap (Dec-25-2022)
    0.442 Billion USD
    World Rank (Jan-07-2022)
    11,181
    Market Cap (Jan-07-2022)
    0.73 Billion USD
    Annual Revenue in USD
    232 Million USD
    Annual Net Income in USD
    -33 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Canada
    Yahoo @ Frankfurt
    Company Website
    WELL HEALTH TECHNOLOGIES

  4. Max India

    World Rank (Jan-05-2024)
    10,669
    Market Cap (Jan-05-2024)
    0.690 Billion USD
    World Rank (Jul-30-2023)
    12,493
    Market Cap (Jul-30-2023)
    0.522 Billion USD
    World Rank (Dec-25-2022)
    24,901
    Market Cap (Dec-25-2022)
    0.053 Billion USD
    World Rank (Jan-07-2022)
    17,383
    Market Cap (Jan-07-2022)
    0.27 Billion USD
    Annual Revenue in USD
    4 Million USD
    Annual Net Income in USD
    1 Million USD
    Annual Results for Period Ending
    Mar-2021 ending year
    Headquarters Country
    India
    Yahoo @ BSE
    Company Website
    Max India Ltd

  5. Vera Therapeutics Inc.

    World Rank (Jan-05-2024)
    10,674
    Market Cap (Jan-05-2024)
    0.689 Billion USD
    World Rank (Jul-30-2023)
    10,207
    Market Cap (Jul-30-2023)
    0.761 Billion USD
    World Rank (Dec-25-2022)
    11,799
    Market Cap (Dec-25-2022)
    0.550 Billion USD
    World Rank (Jan-07-2022)
    14,196
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Headquarters Country
    USA
    Company Website
    VERA THERAPEUTICS, INC.

  6. Polypeptide Group AG

    World Rank (Jan-05-2024)
    10,686
    Market Cap (Jan-05-2024)
    0.688 Billion USD
    World Rank (Jul-30-2023)
    9,898
    Market Cap (Jul-30-2023)
    0.803 Billion USD
    World Rank (Dec-25-2022)
    8,940
    Market Cap (Dec-25-2022)
    0.897 Billion USD
    World Rank (Jan-07-2022)
    3,795
    Market Cap (Jan-07-2022)
    4.12 Billion USD
    Annual Revenue in USD
    282 Million USD
    Annual Net Income in USD
    47 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Switzerland
    Company Profile
    PolyPeptide Group AG is a Contract Development and Manufacturing Organization (CDMO) focusing on proprietary and generic GMP(Good manufacturing practice) grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products company. The company annual revenue is 223 million EUR, annual operating income is 44.3 million EUR and total assets are 375.9 million EUR as on 2020. The headquarters is in Switzerland.
    Company Website
    POLYPEPTIDE GROUP AG

  7. Beijing Scitop Bio-Tech Co. Ltd

    World Rank (Jan-05-2024)
    10,691
    Market Cap (Jan-05-2024)
    0.687 Billion USD
    World Rank (Jul-30-2023)
    11,885
    Market Cap (Jul-30-2023)
    0.574 Billion USD
    World Rank (Dec-25-2022)
    11,198
    Market Cap (Dec-25-2022)
    0.607 Billion USD
    World Rank (Jan-07-2022)
    9,570
    Market Cap (Jan-07-2022)
    0.98 Billion USD
    Headquarters Country
    China
    Company Website
    BEIJING SCITOP BIO-TECH CO., LTD.

  8. Stemline Therapeutics

    World Rank (Jan-05-2024)
    10,696
    World Rank (Jul-30-2023)
    10,696
    World Rank (Dec-25-2022)
    10,696
    World Rank (Jan-07-2022)
    10,696
    Headquarters Country
    USA
    Company Profile

    Menarini Group Completes acquired Stemline Therapeutics in June 2020.

    Stemline Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. ELZONRIS (tagraxofusp), a targeted therapy directed to CD123, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with blastic plasmacytoid dendritic cell neoplasm (BPDCN).

  9. Tianjin Lisheng Pharmaceutical

    World Rank (Jan-05-2024)
    10,697
    Market Cap (Jan-05-2024)
    0.687 Billion USD
    World Rank (Jul-30-2023)
    11,127
    Market Cap (Jul-30-2023)
    0.647 Billion USD
    World Rank (Dec-25-2022)
    11,452
    Market Cap (Dec-25-2022)
    0.582 Billion USD
    World Rank (Jan-07-2022)
    12,163
    Market Cap (Jan-07-2022)
    0.62 Billion USD
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    TIANJIN LISHENG PHARMACEUTICAL

  10. Travere Therapeutics Inc.

    World Rank (Jan-05-2024)
    10,719
    Market Cap (Jan-05-2024)
    0.683 Billion USD
    World Rank (Jul-30-2023)
    7,507
    Market Cap (Jul-30-2023)
    1.287 Billion USD
    World Rank (Dec-25-2022)
    7,234
    Market Cap (Dec-25-2022)
    1.285 Billion USD
    World Rank (Jan-07-2022)
    6,953
    Market Cap (Jan-07-2022)
    1.70 Billion USD
    Annual Revenue in USD
    212 Million USD
    Annual Operating Income in USD
    -251 Million USD
    Annual Net Income in USD
    -278 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile

    Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The headquarters is in USA.

    Facts About Company

    Travere Therapeutics Annual Total Revenue for year ending Dec-2022 was 212 million USD and and Net loss for year ending Dec-2022 was -278 million USD.

    Travere Therapeutics Annual Total Revenue for year ending Dec-2021 was 227 million USD and and Net loss for year ending Dec-2021 was -180 million USD.

    As on 2022, Travere Therapeutics has 462 employees.

    Company Website
    TRAVERE THERAPEUTICS, INC.

Share